We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00027300
Recruitment Status : Completed
First Posted : December 3, 2001
Last Update Posted : January 9, 2017
Sponsor:
Collaborator:
Elan Pharmaceuticals
Information provided by:
Biogen